Advertisement
Singapore markets open in 7 hours 6 minutes
  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     
  • S&P 500

    5,079.17
    +8.62 (+0.17%)
     
  • Dow

    38,525.06
    +21.37 (+0.06%)
     
  • Nasdaq

    15,751.82
    +55.18 (+0.35%)
     
  • Bitcoin USD

    64,852.62
    -1,915.04 (-2.87%)
     
  • CMC Crypto 200

    1,405.64
    -18.46 (-1.30%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Gold

    2,336.50
    -5.60 (-0.24%)
     
  • Crude Oil

    82.65
    -0.71 (-0.85%)
     
  • 10-Yr Bond

    4.6560
    +0.0580 (+1.26%)
     
  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     
  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     
  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Compared to Estimates, Nutrien (NTR) Q1 Earnings: A Look at Key Metrics

Nutrien (NTR) reported $6.11 billion in revenue for the quarter ended March 2023, representing a year-over-year decline of 20.2%. EPS of $1.11 for the same period compares to $2.70 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $6.67 billion, representing a surprise of -8.48%. The company delivered an EPS surprise of -27.92%, with the consensus EPS estimate being $1.54.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how Nutrien performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Tonnes Sold - Potash - North America: 854 KTon versus 1114.39 KTon estimated by four analysts on average.

  • Average Selling Price per Tonne - Nitrogen - Solutions, nitrates and sulphates: 310 $/Ton compared to the 279.03 $/Ton average estimate based on four analysts.

  • Average Selling Price per Tonne - Nitrogen - Urea: 617 $/Ton versus 485.74 $/Ton estimated by four analysts on average.

  • Average Selling Price per Tonne - Nitrogen - Ammonia: 721 $/Ton versus the four-analyst average estimate of 746.29 $/Ton.

  • Sales- Potash [$M]: $1.08 billion compared to the $1.39 billion average estimate based on five analysts. The reported number represents a change of -44.6% year over year.

  • Net Sales- Eliminations: -$342 million versus the five-analyst average estimate of -$554.30 million.

  • Sales- Phosphate [$M]: $572 million compared to the $597.91 million average estimate based on five analysts. The reported number represents a change of -17.8% year over year.

  • Sales- Nitrogen [$M]: $1.42 billion versus the five-analyst average estimate of $1.46 billion. The reported number represents a year-over-year change of -22.8%.

  • Sales- Retail Total: $3.42 billion compared to the $3.74 billion average estimate based on five analysts. The reported number represents a change of -11.4% year over year.

  • Potash Net Sales- Offshore: $659 million versus the four-analyst average estimate of $824.36 million. The reported number represents a year-over-year change of -35.2%.

  • Potash Net Sales- North America: $343 million versus $504.15 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -58.8% change.

  • Net Sales- Nitrogen: $1.31 billion versus the four-analyst average estimate of $1.33 billion. The reported number represents a year-over-year change of -10.3%.

View all Key Company Metrics for Nutrien here>>>

Shares of Nutrien have returned -12.9% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Nutrien Ltd. (NTR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research